hydrolyzed casein 0.25%, yeast extract 0.3%, beef extract 0.2%, soybean meal 0.2%, calcium carbonate 0.1%, pH 7.4).
Isolation
of Antibiotic GE2270 A After 72 hours fermentation the antibiotic, GE2270A, was found both in the supernatant and adsorbed on the mycelium. The filtrate was adjusted to pH 7.0 and extracted with 50 liters of ethyl acetate. The crude antibiotic (41 5 mg) was precipitated from the concentrated organic phase upon addition of petroleum ether. The mycelial cake was extracted twice with 20 liters of methanol and the pooled extracts were concentrated under vacuumto the water residue. This solution was extracted twice with ethyl acetate. The crude antibiotic (6.06 g) was precipitated from the concentrated organic phase upon addition of petroleum ether. Part of this crude preparation (3g) was applied to a 300g (230~400 mesh) silica gel column equilibrated with CH2C12. The column was developed sequentially with 2 liters CH2C12,and then with 1.5 liters of each of the following mixtures of 96:4, 94:6, 92:8, 90: 10 and 88 : 12) . The fractions containing the purified GE2270 A were pooled and concentrated to an oily residue. GE2270 A (600 mg) was precipitated upon addition of petroleum ether.
HPLC
HPLCanalysis was performed on an Altex Ultrasphere (5 /im) ODS 4.6 x 250 mmcolumn connected to a Brownlee Labs RP 18 (5/zm) precolumn eluted at 1.8ml/minute flow rate with a linear gradient of 45% to 70%of eluent A in 20 minutes. The elution phases were: CH3CN-18him sodium phosphate (70 : 30) (phase A) and CH3CN-18mMsodium phosphate (10 : 90) (phase B). The phases were brought to pH 7.0 with NaOH.UVdetection was at 254nm.
Potentiometric Analysis
Titration of the antibiotic was carried out in Methyl Cellosolve -water (4 : 1) with 0.1 n KOHand with 0.1 n HC1 and in glacial acetic acid with 0.1 n HC1O4.
FAB-MS Studies
Positive ion FABspectra were obtained on a Kratos MS-50double focusing mass spectrometer, using 8 kV accelerating voltage. Asaddle field atom gun was used with Xe gas (2 x 10~5 torr pressure indicated on the source ion gauge) at 6kV voltage and 1 mAcurrent. The sample, dissolved in 0.2n acetic acid in ethanol-ethyl acetate (1 : 1) was mixed with thioglycerol matrix. Using HR peak matching methods the precision was about +0.02 dalton.
Acid Hydrolysis Followed by GC-MS Analysis Acid hydrolysis was carried out at 105°C for 20 hours in the presence of 6n HC1containing 1% phenol. The acid hydrolysate (2mg) was derivatized at 90°C for 1 hour with 2n HC1in anhydrous propanol and then with a 10%solution of pentafluoropropionic anhydride in anhydrous dichloromethane.
The analysis was carried out on a Hewlett Packard HP5985B GC-MS system equipped with a «-propionyl-L-valine ter/-butylamide polysiloxane-coated fused silica capillary column (25 mx 0.2 mmi.d.; OS641 1, C.G.C. Analytic); temperature program: 80°C for 4 minutes, then increasing at 4°C/minute.
MIC Determinations
Efrotomycin was a gift of Merck Co. Pulvomycin was purified from fermented mycelium of Streptoverticillium netropsis and was characterized by spectroscopic analyses.
MIC were determined by microbroth dilution methodology, except for Clostridium difficile, Propionibacterium acnes and Bacteroidesfragilis (agar dilution). Inocula were 104~105 cfu per ml or per spot (104" color changing units (CCU)/ml for Ureaplasma ureafyticum). With the exception of Candida albicans (grown at 30°C), all microorganisms were cultured at 37°C. MICwere read at 18~24 hours, except for Neisseria gonorrhoeae, Moraxella catarrhalis, Haemophilus influenzae, C. difficile, B. fragilis, and P. acnes (48 hours). N. gonorrhoeae and H. influenzae were incubated in a 5%CO2atmosphere; anaerobes were incubated in an anaerobic gas mixture. Chlamydiatrachomatis was cultivated in microtiter plates on cycloheximide treated McCoycell monolayers, in Eagle's MEMmedium (Gibco) with 10% fetal calf serum, in a 5% CO2 atmosphere. Inocula were prepared so as to give 30~60 inclusions per 300 x microscope field. After 48 hours chlamydial inclusions were stained with fluorescein-labeled monoclonal antibody to the major outer membraneprotein (Syva) and counted by fluorescence microscopy. The MICwas taken as the concentration at which inclusions were no longer seen and cellular morphology was normal.
Experimental Infections
CDF1mice (Charles River) weighing 18~22g were infected ip with 1.5 x 106 cells of Staphylococcus aureus Smith ATCC19636 in 0.5ml of 5% Difco bacteriological mucin. This challenge corresponded to about 80 LD50 of the infecting organism. GE2270 A was administered iv, immediately after infection. The ED50was calculated by the Spearman and Karber method9* from the percentage of surviving animals (day 7th) at each dosage.
Mechanism of Action of GE2270 A
Bacillus subtilis 566/1 (thyA, thyB) was grown at 37°C in a rotary bath in Davis-Mingioli minimal medium with glucose 2%, asparagine 0.1 g/liter, Difco Casamino acids 5 g/liter, and thymine I mg/liter. Whenthe optical density (590nm) of the culture reached 0.4, it was divided in five parts. To four of these, precursors of DNA(2mCi/liter [3H]thymidine+ I mg/liter unlabeled thymine), RNA(l mCi/liter 3H-+ lO mg/liter unlabeled uridine), protein (1 mCi/liter 3H-+ 1 mg/liter unlabeled tryptophan), and cell wall peptidoglycan (2 mCi/liter 3H-+ 3.5 mg/liter unlabeled TV-acetylglucosamine) were added. The fifth culture was used to monitor cell density. After 15 minutes of incorporation, each culture was further divided into three parts: untreated control, 2 mg/liter GE2270A, and positive control. The positive controls were 50 mg/liter nalidixic acid (DNA), 10 mg/liter rifampicin (RNA), 25 mg/liter chloramphenicol (protein), and 100mg/liter ampicillin (cell wall). At various times, up to 60 minutes, 0.1 ml samples were added to 2ml ice-cold 5% (w/v) TCAand filtered on glass fiber filters. Samples containing tritiated tryptophan were heated for 1 5 minutes at 75°C before filtering. The filters were placed in 1 5 ml of Insta-Fluor (Packard) and counted in a liquid scintillation spectrometer. Moderate growth with smooth and thin surface light pink (l-A-9), abundant formation of light pink (l-C-9) aerial mycelium Abundant growth with thick and wrinkled surface light coral pink (l-A-10), moderate production of light pink aerial mycelium Very scarce growth with smooth and thin surface, moderate production of light pink aerial mycelium Moderate growth with smooth and thin surface colorless, aerial mycelium absent Good growth with smooth surface light orange with a pinkish tinge (9-A-7) Moderate growth with slightly wrinkled surface light amber pink (10-A-6) Poor growth with smooth and flat surface colorless Moderate growth with smooth surface coral pink (2-F-9) Poor growth with smooth and thin surface colorless to light pink (2-A-8) No growth Good growth with smooth surface light orange with a pinkish tinge (9-A-7) The vegetative mycelium formed long and irregularly branched filaments (0.5 to 1.0 fxm) penetrating the agar and forming a compact growth on its surface. Color ranged from light coral to pink coral on most media tested. The myceliumgrown in liquid or in solid media remained unfragmented. The aerial mycelium was formed of long, wavy and thin hyphae with few lateral branches. The aerial mycelium had a white-pink color. The sporangia (6.0 to 8.0^m long and 1.0 to 1.2^im wide) were single or in groups along the hyphae of the aerial mycelium and were supported by short sporangiophore (1.0 to 2.0 um long). Each sporangium contained a pair of fusiform straight spores (3.0 to 3.5 x 1.0 to 1.2fim) separated by a transverse septum. The spores became motile by means of peritrichous flagella when released from the sporangia. No relevant morphological differences were observed by direct comparison of the producing strain and Planobispora rosea strain ATCC238661 5). GE2270is detectable also in cultures of strain ATCC 23866, when grown in proper conditions.
Activity of GE2270 A in Cell Free Eukaryotic and Procaryotic Systems

Chemotaxonomical Characteristics of the Producing Strain
The cell wall diamino acid of the GE2270A producing strain was found to be raestf-diaminopimelic acid. Madurose (3-O-methyl-D-galactose) was the only diagnostic sugar detected. The fatty acid pattern consisted of a complex mixture of saturated and unsaturated linear, as well as iso and 10-methyl branched fatty acids. Phosphatidylinositol-, phosphatidylethanolamine-, phosphatidylglyceroland glucosaminecontaining phospholipids were all found in the polar lipid extract. The sole isoprenoid quinones were diand tetra-hydrogenated menaquinones with nine isoprene units. These characteristics, in accordance with the literature16), confirm the strain as a memberof the genus Planobispora. This strain has been deposited as P. rosea ATCC53773.
Structure and Physico-chemical Characteristics of GE2270A The purity of the isolated antibiotic was assessed by HPLC analysis (Rt 14.9 minutes) and TLC (Rf 0.36 on silica gel plates eluted with dichloromethane-methanol, 9 : 1), both with UVdetection. GE2270 A has characteristic UVabsorption maximawhich are reported in Table 4 . The antibiotic was obtained as a white precipitate sparingly soluble in water. No ionizable functions of strong or mediumstrength were detected from the titration in water. In acetic acid a weak basic function was revealed.
The antibiotic has a MW1,289 daltons. The formula C56H55N15O10S6was determined by precise FAB-MS.
GC-MSof an acid hydrolysate of GE2270
factor Arevealed the presence of three amino acids:
Glycine, L-proline and L-serine. The enantiomers were distinguished by comparison of Rt's on the chiral GCcolumn with those of standard amino acids17). The structure of GE2270 A, reported in Fig. 1 , was elucidated by NMRand MS spectrometry studies which are reported in a companion paper18).
Antibiotic GE2270 A belongs to the group of antibiotics classified by Berdy19) as thiazolyl peptides. These modified peptides, which include Fig. 1 . Structure ofGE2270 A.
JULY 1991 thiostrepton20), nosiheptide2 1), micrococcin22'23), thiocillin24), sulfomycin25), berninamycin25) and thioxamycin26), have a commonframework characterized by a macrocycle containing thiazoles and one pyridine ring, or reduced pyridine ring, connected to a peptidic side chain. Some of these antibiotics, such as thiostrepton and nosiheptide, have an extra peptidic macrocycle which is not present in GE2270A. Micrococcin and thiocillin show somesimilarities to GE2270A in the chromophoric part centered on the pyridine ring which is conjugated to four thiazole rings although in a different sequence in GE2270A. In comparison to thiazolyl peptides, the GE2270 A structure is original in many features such as the sequence of the peptidic backbone from which it derives, the number of amino acid units which are precursors of the macrocycle and the lack of diolehydroalanine and threonine which are frequently present in those antibiotics. GE2270A is also unique in having methyl and methoxy-methylene substituents at the C-5 position of two out of the six thiazole rings present in the molecule. Antibacterial Activity of GE2270 A In Vitro and in Experimental Infection Table 5 shows the antibacterial spectrum of GE2270A. It is active against all of the Gram-positive bacteria and particularly active against the anaerobe P. acnes. It is also active against Mycobacterium tuberculosis, with an MIC of 1 jug/ml. Among Gram-negative bacteria, it is quite active against B. fragilis (an anaerobe) and M. catarrhalis. It is not active against the yeast, C. albicans. In the murine model of S. aureus septicemia, GE2270 A had an ED50 of 1.13mg/kg iv.
Mechanismof Action GE2270 A inhibited bacterial growth by 80~90% at 2/zg/ml. At this concentration the antibiotic blocked protein synthesis within 5 minutes of addition as shown in Fig. 2 . The other macromolecular syntheses were partially or totally blocked after 15 minutes or more. This indicates that the antibacterial action of GE2270A is mediated by inhibition of protein synthesis. In cell free systems, the antibiotic inhibited poly(17)-directed prokaryotic protein synthesis (IC50 0.34jig/ml). This inhibitory concentration is in the range of MICs against sensitive bacteria. Eukaryotic protein synthesis was not inhibited up to the solubility limit of the antibiotic as shown in Fig. 3 . In other studies, the molecular target of the antibiotic was shown to be protein synthesis elongation factor Tu (EF-Tu)27). å Rabbit reticulocyte lysate system, å¡ Escherichia coli system.
Discussion and Conclusions
Antibiotic GE2270A is produced by a strain which belongs to the Planobispora genus. Few species of this genus of rare Actinomycetales have been previously described5~7) and none has yet been reported to produce antibacterial activity. Antibiotic GE2270A is structurally related to thiazolyl peptides and has some structural similarity with micrococcin and thiocillin in the chromophoric part of the molecule. These antibiotics are produced by bacteria and are thus examples of closely related structures which are produced by microorganisms of different taxa. The thiazolyl peptide antibiotics thiostrepton28), nosiheptide29), and micrococcin30'3X) are known inhibitors of bacterial protein synthesis and bind to the ribosome. GE2270A has also been found to be an inhibitor of bacterial protein synthesis at the elongation step. However, its molecular target is EF-Tu which is the factor required for the binding of aminoacyl-tRNA to the A site of the ribosome27). Thus, although GE2270 A is structurally related to thiazolyl peptide antibiotics, it is functionally related to kirromycin-like antibiotics32) and pulvomycin33'340 for the EF-Tu target.
GE2270 A is different from the other EF-Tu inhibitors in its spectrum of antibacterial activity (Table  5 ). For example, efrotomycin, a kirromycin-like antibiotic, is highly active against N. gonorrhoeae but inactive against Staphylococci and most enterococcal isolates; pulvomycin is not active against Streptococci; GE2270A is highly active against all Gram-positive tested, but not against N. gonorrhoeae. GE2270 A, kirromycin and pulvomycin do not penetrate into E. coli but are active against EF-Tu extracted from this organism31~33). GE2270Aalso inhibited cell free protein synthesis in a system derived fromE. coli.
